New Directions in Influenza Management: The Pharmacist's Guide to Patient Identification, Testing, and Antiviral Use
Date & Time:
Wednesday, November 18, 2020
6:30 pm - 6:45 pm NISHP Business Meeting
6:45 pm - 7:45 pm Presentation
Virtual Meeting via Zoom
Katherine Lusardi, PharmD
Clinical Pharmacy Specialist Antimicrobial Stewardship
UAMS Medical Center
Little Rock, AR
Register online below. Registration deadline is Monday, November 16, 2020 at 12:00 noon.
This program is free to ICHP members. However, must still complete the check-out process to register. Pre-registration is required.
Learning Objectives for Pharmacists:
1. Identify appropriate candidates for antiviral therapy based on risk for influenza-related complications, in accordance with current guideline recommendations
2. Assess the need for influenza treatment based on patient signs, symptoms, and accurate interpretation of appropriate diagnostic tests when necessary
3. Recommend individualized antiviral treatment plans for patients with, or at risk for, influenza in accordance with the latest evidence
This CE activity is jointly provided by ProCE, Inc. and Paradigm Medical Communications, LLC. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-243-L01-P has been assigned to this live knowledge-based CE activity. This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Completion of the evaluation and the post-test are required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Please complete this pre-test
prior to the meeting.